SeekingAlpha · Nov 3, 2026
Paul Mueller: Betting On The Reshoring Of Pharma Manufacturing
Paul Mueller is leveraging pharma modular systems and U.S. reshoring trends to drive robust revenue and margin growth. Read more on MUEL stock here.
OTC · MUEL
Industrials · Manufacturing - Metal Fabrication
$415.53
Down-$34.47 (-7.66%)
Updated Nov 5, 2026, 1:42 PM
SID Score
5.2/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance · MUEL
1M range · 0 trading sessions · Daily adjusted prices
MUEL does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
The latest Smart Investors Daily articles mentioning MUEL.
Company
Market Activity
Research & News


MUEL research
Filterable reporting and market headlines.
Filters are reflected in the page URL for sharing and back-button support.
2 matching articles.
SeekingAlpha · Nov 3, 2026
Paul Mueller is leveraging pharma modular systems and U.S. reshoring trends to drive robust revenue and margin growth. Read more on MUEL stock here.
Yahoo · Oct 30, 2026
SPRINGFIELD, Mo., Oct. 30, 2026 (GLOBE NEWSWIRE) -- Paul Mueller Company (OTC: MUEL) today announced earnings for the Third quarter ended September 30, 2026. PAUL MUELLER COMPANY NINE-MONTH REPORTUnaudited(In thousands)CONSOLIDATED STATEMENTS OF INCOME Three Months Ended Nine Months Ended Twelve Months Ended September 30 September 30 September 30 2026 2025 2026 2025 2026 2025 Net Sales $92,460 $61,375 $252,650 $192,859 $346,792 $263,333 Cost of Sales 64,266 45,348 181,199 131,146 243,254 175,811
The latest Smart Investors Daily articles mentioning MUEL.